INTRODUCTION: Preliminary reports suggested high incidence and mortality rates of SARS‑ CoV 2 infection in patients receiving kidney replacement therapy. OBJECTIVES: We aimed to describe the incidence and outcomes of COVID‑ 19 in hemodialysis patients. PATIENTS AND METHODS: We conducted a retrospective multicenter cohort study on the incidence and mortality of COVID‑ 19 in hemodialysis patients as compared with the general adult population in the period from the beginning of the pandemic until the commencement of the SARS‑ CoV 2 vaccination program. The study population included all patients who were receiving hemodialysis in any of the 14 dialysis units of Pomerania Province, Poland on December 31, 2019 and all individuals who were starting long‑ term hemodialysis between January 1, 2020 and January 31, 2021, amounting to a total of 1567 patients. Data on the general population were obtained from reports of the health authorities. RESULTS: The absolute cumulative incidence of SARS‑ CoV 2 infection in hemodialysis patients was 22.4%, and after standardization for age it was 3.98-fold higher compared with the general population (P <0.001). The epidemic trajectory of both groups ran in parallel, but the increase and decline in the number of new cases occurred earlier in hemodialysis patients. The fatality rate of COVID‑ 19 among hemodialysis patients was 30.4%. It was the highest among the oldest patients, reaching 43.81% in individuals aged 75 years or older (P = 0.003). Age‑ standardized fatality and mortality rates in hemodialysis patients were 5.5- and 10.9-fold higher than in controls, respectively (both P <0.001). CONCLUSIONS: The results of this study show the extremely high mortality rate of COVID‑ 19 in hemodialysis patients during the first and second waves of the epidemic in Pomerania Province, before the vaccination era.
INTRODUCTION: Preliminary reports suggested high incidence and mortality rates of SARS‑ CoV 2 infection in patients receiving kidney replacement therapy. OBJECTIVES: We aimed to describe the incidence and outcomes of COVID‑ 19 in hemodialysis patients. PATIENTS AND METHODS: We conducted a retrospective multicenter cohort study on the incidence and mortality of COVID‑ 19 in hemodialysis patients as compared with the general adult population in the period from the beginning of the pandemic until the commencement of the SARS‑ CoV 2 vaccination program. The study population included all patients who were receiving hemodialysis in any of the 14 dialysis units of Pomerania Province, Poland on December 31, 2019 and all individuals who were starting long‑ term hemodialysis between January 1, 2020 and January 31, 2021, amounting to a total of 1567 patients. Data on the general population were obtained from reports of the health authorities. RESULTS: The absolute cumulative incidence of SARS‑ CoV 2 infection in hemodialysis patients was 22.4%, and after standardization for age it was 3.98-fold higher compared with the general population (P <0.001). The epidemic trajectory of both groups ran in parallel, but the increase and decline in the number of new cases occurred earlier in hemodialysis patients. The fatality rate of COVID‑ 19 among hemodialysis patients was 30.4%. It was the highest among the oldest patients, reaching 43.81% in individuals aged 75 years or older (P = 0.003). Age‑ standardized fatality and mortality rates in hemodialysis patients were 5.5- and 10.9-fold higher than in controls, respectively (both P <0.001). CONCLUSIONS: The results of this study show the extremely high mortality rate of COVID‑ 19 in hemodialysis patients during the first and second waves of the epidemic in Pomerania Province, before the vaccination era.
Authors: Leszek Tylicki; Bogdan Biedunkiewicz; Ewelina Puchalska-Reglińska; Ryszard Gellert; Michel Burnier; Jacek Wolf; Alicja Dȩbska-Ślizień Journal: Front Med (Lausanne) Date: 2022-09-08
Authors: Leszek Tylicki; Ewelina Puchalska-Reglińska; Piotr Tylicki; Aleksander Och; Karolina Polewska; Bogdan Biedunkiewicz; Aleksandra Parczewska; Krzysztof Szabat; Jacek Wolf; Alicja Dębska-Ślizień Journal: J Clin Med Date: 2022-01-06 Impact factor: 4.241
Authors: Bogdan Biedunkiewicz; Leszek Tylicki; Ewelina Puchalska-Reglińska; Alicja Dębska-Ślizień Journal: Int J Environ Res Public Health Date: 2022-01-07 Impact factor: 3.390
Authors: Piotr Tylicki; Karolina Polewska; Aleksander Och; Anna Susmarska; Ewelina Puchalska-Reglińska; Aleksandra Parczewska; Bogdan Biedunkiewicz; Krzysztof Szabat; Marcin Renke; Leszek Tylicki; Alicja Dębska-Ślizień Journal: Viruses Date: 2022-02-22 Impact factor: 5.048